Biocatalytic drugs, including natural and artificial enzymes that can accelerate biochemical
reactions, are promising tools to address redox imbalances, metabolic disorders and …

Drug induced liver injury (DILI) is a relatively rare hepatic condition in response to the use of
medications, illegal drugs, herbal products or dietary supplements. It occurs in susceptible …

There are currently more than 1000 prescription medications available for use in the United
States and more than 100,000 over-the-counter herbal and dietary supplements (HDS) …

ABSTRACT Drug-Induced Liver Injury (DILI) constitutes hepatic damage attributed to drug
exposure. DILI may be categorized as hepatocellular, cholestatic or mixed and might also …

Idiosyncratic drug-induced liver injury (IDILI) remains a significant problem for patients and
drug development. The idiosyncratic nature of IDILI makes mechanistic studies difficult, and …

Idiosyncratic drug-induced liver injury (DILI) is an infrequent but important cause of liver
disease. Newly identified causes of DILI include the COVID vaccines, turmeric, green tea …

Drug-induced liver injury (DILI) has become a serious public health problem. For the
management of DILI, discontinuation of suspicious drug or medicine is the first step, but the …

Currently, hundreds of herbal products with potential hepatotoxicity were available in the
literature. A comprehensive summary and analysis focused on these potential hepatotoxic …

Numerous publications contributed to the expanding knowledge base about drug-induced
liver injury (DILI) in 2015. New findings from the US Drug Induced Liver Injury Network …

Background With increasing use of pharmaceuticals, drug-induced liver injury (DILI) has
become a significant therapeutic challenge to physicians all over the world. Drugs based on …